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ABSTRACT: Gated ion transport across biological mem-
branes is an intrinsic process regulated by protein channels.
Synthetic anion carriers (anionophores) have potential
applications in biological research; however, previously
reported examples are mostly nonspeciﬁc, capable of
mediating both electrogenic and electroneutral (nonelectro-
genic) transport processes. Here we show the transmembrane
Cl− transport studies of synthetic phenylthiosemicarbazones
mimicking the function of acid-sensing (proton-gated) ion
channels. These anionophores have remarkable pH-switchable
transport properties with up to 640-fold increase in transport
eﬃcacy on going from pH 7.2 to 4.0. This “gated” process is
triggered by protonation of the imino nitrogen and
concomitant conformational change of the anion-binding thiourea moiety from anti to syn. By using a combination of two
cationophore-coupled transport assays, with either monensin or valinomycin, we have elucidated the fundamental transport
mechanism of phenylthiosemicarbazones which is shown to be nonelectrogenic, inseparable H+/Cl− cotransport. This study
demonstrates the ﬁrst examples of pH-switchable nonelectrogenic anion transporters.
■ INTRODUCTION
Transmembrane ion transport processes facilitated by protein
channels and carriers across biological lipid bilayer membranes
are essential for life.1 There has been much eﬀort devoted to
the development of small molecule anion carriers that have
potential as future treatments for diseases such as cystic ﬁbrosis
or cancer.2 Prodigiosin is a natural product, best known as one
of the most potent anion transporters that facilitate H+/Cl−
cotransport; hence, the transport of chloride can dissipate a
transmembrane pH gradient (Figure 1).3 pH gradient
dissipation has been observed within cancer cells and may be
a trigger for apoptosis.4 The transport of protons and chloride
are inseparable because protonated prodigiosin is unable to
diﬀuse through the lipid bilayer in the absence of chloride5 (or
another bound anion, e.g. Cl−/NO3
− exchange6); thus, the
eﬀect of prodigiosin is nonelectrogenic.5 There are other classes
of structurally similar transporters that function in a fashion
similar to that of prodigiosin; these include the tambjamines,7
perenosins,8 and others.9 In the seminal work by Peŕez-Tomaś,
Quesada et al., tambjamines were shown to induce the
combined eﬀect of cytosolic acidiﬁcation and hyperpolarization
of cellular membranes on cancer stem cells, leading to selective
elimination of the aﬀected cell population.7b
Prodigiosin and other similar classes of H+/Cl− cotransport-
ers are active across the pH range of 4−7; therefore, it would be
very beneﬁcial for biological studies if synthetic carriers could
facilitate H+/Cl− cotransport explicitly in acidic intracellular
organelles such as lysosomes. Furthermore, transporters that
can eﬀectively switch ON in an acidic environment, but OFF at
neutral pH, would mimic the function of acid-sensing (proton-
gated) ion channels.10 There are only a few reports of pH-
dependent transporters,11 and carriers that possess a highly
speciﬁc pH-inﬂuenced ON/OFF function are still unavailable.
Our group, in collaboration with Jolliﬀe and co-workers, has
previously reported thiosquaramides and an oxothiosquaramide
as pH-dependent anionophores.12 However, these carriers can
mediate electrogenic transport and hence are capable of
depolarizing the membrane potential;13 unfortunately, this is
undesirable for certain cellular studies.14 The challenge is to
develop pH-switchable anionophores with truly prodigiosin-like
transport properties.
Phenylthiosemicarbazones are structurally similar to phenyl-
thioureas; however, they contain an additional imine group
directly adjacent to the thiourea anion binding site.15 Herein we
report three phenylthiosemicarbazones 1−3 (Figure 2) as a
new class of anionophores that have excellent pH-switchable
anion transport properties. To evaluate the eﬀect of electron-
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donating or -withdrawing substituents on the para-position of
the phenyl ring, the unsubstituted 1 (σp 0.0), methoxy 2 (σp
−0.27), and triﬂuoromethyl 3 (σp 0.54) were synthesized. The
Hammett constant (σ)16 is a descriptor of the electron-
withdrawing or -donating eﬀect of a speciﬁc substituent; it has
been used extensively to correlate the hydrogen bond donor
acidity.17 Chloride anion binding and transmembrane transport
activities of 1-hexylidene-4-phenylthiosemicarbazones 1−3
were compared with the analogous 1-hexyl-3-phenylthioureas
4−617c and squaramides 7−9.12,18 Thiosemicarbazones 1−3
were found to be more eﬀective pH-switchable anion
transporters (from neutral to acidic environment) than
previously reported oxothiosquaramide 8 and thiosquaramide
9. More importantly, we have shown that chloride and proton
transport by thiosemicarbazones is an inseparable electro-
neutral process (elucidated by using the newly developed
cationophore-coupled KCl eﬄux assays from our most recent
work)19 in the same fashion as the H+/Cl− symport properties
of prodigiosin. Therefore, we have developed the ﬁrst examples
of a new class of pH-switchable nonelectrogenic anion
transporters.
■ RESULTS AND DISCUSSION
Synthesis, Solid-State Structural Analysis, and Anion
Binding Studies. Thiosemicarbazones 1−3 were synthesized
by the condensation of the corresponding phenylthiosemicar-
bazides with hexanal in absolute ethanol, with yields of 47−52%
after recrystallization from a ethanol/pentane mixture. Phenyl-
thiosemicarbazides (OCH3 and CF3 analogues) were prepared
by the reaction of hydrazine monohydrate with the appropriate
phenyl isothiocyanate in 2-propanol. The rearrangement of
thiosemicarbazones to ﬁve-membered heterocyclic thiadiazoles
is well documented;20 therefore, 2-phenylamino-5-pentyl-1,3,4-
thiadiazole 10 was prepared from 1 via an oxidative cyclization
and used as a control in the transmembrane transport studies.
The resolved X-ray structure of 10 conﬁrmed the thiadiazole
heterocyclic structure (see Supporting Information). Solid-state
structures of all three thiosemicarbazones 1−3 revealed that the
thiourea moieties adopt a ﬂat planar anti-conformation,
presumably due to an intramolecular hydrogen bond (H-
bond) between the thiourea-N(1)H and the lone pair electrons
of imino-N(3), as shown in Figure 3a for compound 3 (see
Supporting Information for structures of 1 and 2). Additionally,
crystal packing interactions of thiosemicarbazones are mainly
established via H-bonds between thiourea N(2)H···S and an
imine NCH···S interaction.
1H NMR titration studies of 1−3 in DMSO-d6/0.5% H2O
with tetrabutylammonium (TBA) chloride did not result in an
observable change in the chemical shifts (Δδ), indicative of no
binding. When using acetone-d6 as a less competitive solvent,
21
titration of 1−3 with TBA-Cl induced a downﬁeld Δδ on the
Figure 1. Prodigiosin-mediated H+/Cl− cotransport (symport)
showing binding of chloride upon protonation at the inner membrane
interface of liposomes, translocation as a neutral complex [Prod·
H+⊃Cl−], and dissociation of H+/Cl− to the external bulk, resulting in
dissipation of pH gradient.
Figure 2. Structures of anionophores used in this study:
thiosemicarbazones 1−3, phenylthioureas 4−6, squaramides 7−9,
and phenylaminothiadiazole 10.
Figure 3. (a) Single-crystal X-ray structure of 3: ORTEP diagram
showing 50% probability anisotropic displacement ellipsoids at 100(2)
K; inset: perspective packing diagram of two molecular structures, all
H atoms are omitted for clarity, except thiourea-H and imine-NCH,
showing intermolecular H-bonds (purple dashed lines), selected H-
bond (donor−acceptor) distances (Å): N(2)···S(1) 3.352(1), N(3)
C···S(1) 3.688(2). (b) Schematic equilibria of thiosemicarbazone
binding conformation toward chloride anion.
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resonance signals of thiourea-NHβ and imine-NCH, indicating
Cl− binding to the thiosemicarbazones via a cleft formed by
NH/CH hydrogen donors. This suggests that the conventional
anion binding thiourea moiety is “locked” by the intramolecular
H-bond interaction between NHα and the lone pair electrons of
imino nitrogen (Figure 3b). The resulting Ka (Table 1) derived
from global ﬁtting analysis22 revealed weak binding toward both
Cl− and NO3
− with similar trends (3 > 1 ≈ 2). Expectedly, the
binding of phenylthioureas 4−6 to Cl− in acetone-d6 was
signiﬁcantly stronger than previously reported studies in
DMSO-d6/0.5% H2O mixture, and the derived Ka for binding
to both Cl− and NO3
− were 2 to 3 orders of magnitude higher
than those of the analogous thiosemicarbazones. The binding
of Cl− and NO3
− to squaramide 7 in acetone-d6 was very
strong, while Ka for Cl
− was too strong (>105 M−1) to be
accurately determined by 1H NMR titration techniques.22a
pH-Regulated Anion Transport Studies. The pH-
dependent chloride transport activities of compounds 1−3
and 10 were investigated using the same liposome-based anion
exchange assay (Cl−/NO3
−) reported for anionophores 4−
9.12,17c Brieﬂy, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line (POPC) large unilamellar vesicles (LUVs, mean diameter
200 nm) were loaded with NaCl (∼500 mM) and suspended in
NaNO3 (∼500 mM), buﬀered to pH 4.0, 5.0, 6.0, 7.2, or 10.0
with appropriate buﬀer reagents (5.0 mM). The Cl−/NO3
−
exchange process was initiated by addition of carriers in a
DMSO solution, and the rate of Cl− eﬄux to the external bulk
was monitored using a chloride ion selective electrode (ISE).
The results of the pH-dependent anion transport studies at
pH 4.0 and 7.2 are shown in Figure 4 (see Supporting
Information section S7.2 for transport rates at other pH
values). The anion transport activities of thiosemicarbazones
1−3 (1.0 mol %) are clearly regulated by pH, signiﬁcantly
enhanced (switches ON) when going from neutral (pH 7.2) to
acidic (pH 4.0) media. Compound 10 (control) did not
mediate any signiﬁcant transport activity at the pHs studied
(see Supporting Information Figure S45). A control Cl−/SO4
2−
exchange assay in POPC liposomes and a Cl−/NO3
− exchange
assay in POPC:cholesterol (7:3) liposomes were studied with
1−3 (1.0 mol %) at pH 4.0 (see Supporting Information
section S7.4−7.5 for details and brief discussion).
Dose−response studies of anionophores at diﬀerent
concentrations were carried out to perform Hill analysis.23a
This was to obtain the Hill coeﬃcient (n), which indicates the
stoichiometry of active carriern:anion supramolecular complex
Table 1. Overview of Association Constants (Ka) for the Complexation of 1−9 toward Cl− and NO3− (as TBA salts), Obtained
from 1H NMR Titrations (400 MHz) at 298 K in DMSO-d6/0.5% H2O and Acetone-d6; Cl
−/NO3
− Transport Activity at pH 7.2




















[mol %]a na EC50(pH 7.2)/EC50(pH 4.0)
b c log Pc
1 −d 16e 3.3e,h 4.7 2.3 0.0074 1.3 640 3.81 (0.52)
2 −d 18e 3.2e,h 1.8 1.3 0.0073 1.2 250 3.74 (0.58)
3 −d 31e 4.3e,h ≫10j −j 0.13 0.7 ≫77 4.70 (0.52)
4 13k 9.2 × 103f 250f 2.7k 0.9k 2.2 0.9 1.2 3.63 (0.35)
5 11k 3.8 × 103f 120f 5.5k 1.3k 4.3 1.0 1.3 3.64 (0.42)
6 26k 2.5 × 104f 780f 0.44k 1.7k 0.51 1.3 0.86 4.62 (0.31)
7 460k >105g,i 1.7 × 104g 0.065k 1.2k 0.077k 1.3k 0.84 4.43 (0.90)
8 60k −m −m 0.68k 0.8k 0.013k 6.3k 52 5.39 (0.69)
9 470l −m −m 0.22l 1.9l 0.027l 2.6l 8.1 4.94 (0.66)
aChloride eﬄux (Cl−/NO3
− antiport) measured by chloride-ISE from POPC LUVs (mean diameter 200 nm) loaded with NaCl (∼500 mM) and
suspended in NaNO3 (∼500 mM), buﬀered to pH 7.2 and 4.0 with phosphate (5.0 mM) and citrate (5.0 mM) sodium salts, respectively. Hill
analysis was performed to obtain the eﬀective concentration to achieve 50% Cl− eﬄux (EC50) at 270 s for each carrier, shown as carrier:lipid molar
percent, and Hill coeﬃcient (n) reveals the stoichiometry of active carriern:anion supramolecular complex mediating the transmembrane transport.
23
bEC50(pH 7.2)/EC50(pH 4.0), an indicator for pH-switchable transport eﬃcacy.
cAveraged log P values (with error in parentheses) calculated via
VCCLab.24 dNo change in Δδ observed. eKa derived from global ﬁtting analysis of Δδ for NHβ and NCH signals.
fKa derived from global ﬁtting
analysis of Δδ for NHα and NHβ signals. gKa derived from global ﬁtting analysis of Δδ for NH and ArH signals to the 1:1 binding model.22 hVery
weak binding (Ka < 5 M
−1) association constant values may be inaccurate. iVery strong binding (Ka > 10
5 M−1); the calculated association constant is
beyond the upper limit that can be reliably obtained from 1H NMR titration studies.22a jToo inactive for Hill analysis: 10 mol % loading of 3 resulted
in 15% Cl− eﬄux at 270 s. kPreviously reported by Busschaert et al.12a,17c,18 lPreviously reported by Elmes et al.12b mNot determined.
Figure 4. Plot of Cl− eﬄux from POPC LUVs (mean diameter 200
nm) at pH 7.2 and 4.0, facilitated by thiosemicarbazones 1−3 (1.0 mol
%, carrier:lipid) and monitored over a period of 5 min using chloride-
ISE. Detergent was added to lyse the vesicles at 300 s, to release
remaining encapsulated Cl− for the 100% chloride concentration at
420 s. Anionophores were added as DMSO solutions (10 μL) to the
POPC LUVs suspension (5.0 mL), and the lipid concentration used
was 1.0 mM. Solid and dashed lines drawn through the data points are
ﬁtted curves to calculate the initial rate of Cl− eﬄux, error bars
corresponding to the SD from three repeats. DMSO was used as a
control. Vertical dotted lines indicate the enhanced transport activities
from pH 7.2 to 4.0.
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mediating transport and the eﬀective concentration of trans-
porter required to achieve 50% anion transport at 270 s (EC50)
for the quantitative transport activity.23b,c Hill analyses for 1−3
were performed at both pH 7.2 and 4.0 and 4−6 at pH 4.0
only. To evaluate the neutral to acidic pH-switchable transport
eﬃcacy of the anionphore, we also reported the ratio of EC50 at
pH 7.2 to EC50 at pH 4.0. The Hill analysis-derived results for
1−9 are summarized in Table 1.
In acidic aqueous media, the transport activities of
thiosemicarbazones switches ON; as a result, 1 and 2 became
the most potent anionophores at pH 4.0 from this study, with
extremely low EC50 values of 0.0074 and 0.0073 mol %. The
Hill coeﬃcients obtained for 1−3 are mostly ∼1, except for 1 at
pH 7.2 which has a Hill coeﬃcient of ca. 2, suggesting a
diﬀerent binding mode for anion transport by 1; i.e., 1:1
complex at pH 4.0 (1:Cl−) and 2:1 complex at pH 7.2 (12:Cl
−).
Interestingly, the pH-switchable properties of thiosemicarba-
zones are signiﬁcantly better than 8 and 9, as 1 emerged as the
best pH-switchable transporter with a remarkable EC50(pH
7.2)/EC50(pH 4.0) ratio of 640, followed by 2 and 3 with 250
and≫77, respectively, all larger than those of 8 (51-fold) and 9
(8-fold). As anticipated, there were negligible diﬀerences in the
transport activities of phenylthioureas 4−6 between pH 7.2 and
4.0 (EC50(pH 7.2)/ EC50(pH 4.0) ≈ 1), similar to squaramide
7.
Conformational Control by Protonation on Imino
Nitrogen. Previously reported compounds 8 and 9 have low
pKa values of 5.3 and 6.6, respectively; hence, the squaramide
NH groups are deprotonated at neutral pH.12 However, the
thiourea NH groups of 1−3 are much less acidic (pKa > 11, see
Supporting Information); therefore, the pH-switchable trans-
port mechanism of the thiosemicarbazones is likely due to
protonation of the imine group, triggering a conformational
change. It is well documented that thiosemicarbazones can
complex with transition metals via the thiourea sulfur and imino
nitrogen atoms,25 and this can facilitate the rearrangement of
the thiourea moiety to the favorable syn-conformation.15b pKb
(protonation of imine) measurements attempted using
potentiometric methods were unsuccessful, possibly due to
the values being too low. Results from 2-D 1H−1H NOESY
NMR studies of 1−3 in DMSO-d6 are consistent with the anti-
conformation observed in the solid-state X-ray structures. In
the presence of 1 equiv of tetraﬂuoroboric acid (HBF4) as a
proton source, chemical exchange between the NH resonances
of thiourea leads us to suggest that protonation of imine
“unlocks” the intramolecular (NHα···NC) H-bond inter-
action (see Supporting Information section S8 and Figures
S65−70 for details and brief discussion).
In acetone-d6,
1H NMR titration studies with HBF4 resulted
in equimolar protonation of 1−3, observable from the slow
exchange between the neutral and protonated states (Figure 5,
see Supporting Information Figures S71−73 for more details).
Proton chemical exchange between the protonated imino-NH
and the proximal thiourea-NHβ with H2O in an acidic
environment was too fast to be observed on the NMR time
scale.26 Nonetheless, the apparent changes in chemical shifts of
the aromatic-CHs, thiourea-NHα, imine-CH, and methylene-
CH2 signals are evidence that lead us to suggest that the
protonation of imino nitrogen perturbed the anti-conformation
of the neutral state. The reversibility between the neutral and
protonated states of 1−3 was ﬁrmly established by 1H NMR
titration studies with HBF4 (toward saturation of protonated
state at 1 equiv), followed by titration with tetrabutylammo-
nium hydroxide up to 1 equiv to achieve full recovery of the
neutral state (see Supporting Information Figures S75−77 for
details). It should be noted that free aldehyde (hexanal) was
not observed during the NMR studies, providing evidence that
the protonated thiosemicarbazones do not undergo imine
hydrolysis during these experiments (see Supporting Informa-
tion Figure S74). Furthermore, UV−vis studies of 1−3 at pH
4.0 demonstrated that these thiosemicarbazones are stable in
the presence of liposomes, monitored over 30 min (see
Supporting Information section S10 and Figures S78−85 for
details and brief discussion), and likewise corroborate the
stability of 1−3 over the duration of the anion transport
experiments.
To gain further structural insights, density functional theory
(DFT) calculations (SMD-M06-2X/6-31+G(d))27 were per-
formed for 1−3 (neutral and protonated) and their Cl−
complexes. The optimized structures for all three thiosemi-
carbazones gave the same outcomes; therefore, only structures
of 1 are illustrated in Figure 6. While the neutral state of 1
showed the same anti-conformation, the host−guest complex of
1⊃Cl− correlates with the 1H NMR binding studies. The
structure of 1·H+ revealed that protonation of the imino
nitrogen perturbs the intramolecular (NHα···NC) H-bond.
Furthermore, the proximal planar arrangement of the imino
hydrogen toward the thiourea sulfur suggests an intramolecular
N+H···S H-bond, which contributes to the stabilization of the
syn-conformation. As a result, the protonated state of 1 binds
Cl− via three H-bonds to form an overall neutral complex 1·
H+⊃Cl−. Calculated binding energies in the gas phase revealed
stronger Cl− binding toward the protonated states of 1−3
compared to the neutral species (see Supporting Information
section S11 for details and discussion). This conformational
control mechanism via protonation emulates the intrinsic
Figure 5. Selected partial 1H NMR (400 MHz, 298 K) spectra of
compound 1 (11.2 mM) in (CD3)2CO, titrated with aliquots of HBF4·
(CH3CH2)2O solution, showing the slow exchange speciation of the
neutral and protonated states of 1. “*” and “Et2O” denote peaks of
NMR solvent and diethyl ether, respectively.
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allosteric properties of acid-sensing (proton-gated) ion channel
proteins.10
We also carried out high-level ab initio calculations28 to
compute the pKa (in parentheses) of the protonated conjugate
acids for 1 (2.01), 2 (1.91), and 3 (1.53) in water (with
uncertainty of ±2, see Supporting Information). Although the
pKa can diﬀer signiﬁcantly in lipid bilayers,
29 the trend of 1 ≈ 2
> 3 will remain similar; the trend suggests that the optimal pH
for anion transport by 3 is the lowest, which provides a
rationale for 3 being less active with a higher EC50. The acidity
of thiourea NHα (governed by the electron-donating or
-withdrawing substituents) will directly aﬀect the strength of
intramolecular (NHα···NC) H-bond, consequently resulting
in the trend of predicted pKa values from competing
intramolecular H-bond and solvation eﬀects. Since NHα of 1
(-H) is more acidic than 2 (-OCH3), the NH
α···NC H-bond
present in compound 1 is thermodynamically more stable,
which inhibits perturbation of the intramolecular H-bond and
the concomitant anti to syn reorganization (see Supporting
Information section S11 for details and discussion). The overall
result is the imino nitrogen of 2 can be expected to be more
Figure 6. DFT (M06-2X/6-31+G(d))-optimized structures of 1 in
neutral and protonated states, and the respective Cl− complexes, with
intramolecular and intermolecular H-bonds shown as purple dashed
lines.
Figure 7. Overview of cationophore-coupled KCl eﬄux assays, measured by chloride-ISE from POPC LUVs (mean diameter 200 nm) loaded with
KCl (300 mM) and suspended in K2SO4 (100 mM), adjusted to pH 4.5 with KOH in citrate (5.0 mM): (a) structure of monensin, and schematic
diagrams showing overall KCl net ﬂux induced by the combination of electroneutral transport processes, including monensin’s K+/H+ exchange and
the anionophore’s H+/Cl− cotransport or Cl−/OH− exchange; (b) structure of valinomycin, and schematic diagram showing overall KCl net ﬂux
from the combination of electrogenic Cl− eﬄux facilitated by anionophore, coupled to the electrogenic K+ transport mediated by valinomycin; (c−f)
plots of Cl− eﬄux facilitated by anionophores (prodigiosin, thiosemicarbazones 1 and 2, and squaramide 7) in the absence or presence of
cationophores (monensin or valinomycin) monitored over a period of 5 min, and detergent was added to lyse the vesicles at 300 s, to release
remaining encapsulated Cl− for the 100% chloride concentration at 420 s. All ionophores were added as DMSO solutions (10 μL) to the POPC
LUVs suspension (5.0 mL), the lipid concentration used was 1.0 mM, and loading concentrations of ionophores are shown as carrier:lipid molar
percent. Solid lines are ﬁtted curves using exponential functions to calculate the initial rate (kinitial) of Cl
− eﬄux, shown as %.s−1; error bars
correspond to the SD from two repeats. Same DMSO, monensin, and valinomycin controls are used in all four plots.
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basic in both aqueous and lipid bilayer membrane environ-
ments; therefore, compound 1 is a better pH-switchable anion
transporter than 2, as shown by the higher EC50(pH 7.2)/
EC50(pH 4.0) ratio. Compound 3 (-CF3) is more acidic than 1,
and this is demonstrated by the fully switched-OFF transport
activity at pH 7.2 (Figure 4). The transport activities for 1−3
are all fully switched OFF at pH 10.0 (see Supporting
Information Figure S38), indicating that the thiosemicarba-
zones must be protonated to mediate transport of anions.
Nonelectrogenic Transport Mechanistic Studies. By
using the combination of two complementary cationophore-
coupled KCl eﬄux assays (Figure 7a and 7b), we can eﬀectively
identify two diﬀerent types of anion transport mechanisms that
cannot be revealed using Cl−/NO3
− exchange experiments:
electrogenic chloride transport and electroneutral H+/Cl−
cotransport. In an electrogenic process, there is a net ﬂow of
charge across a membrane (Figure 7b). In an electroneutral
process (Figure 7a), the charge is balanced either by back
transport of a species with the same charge (i.e., Cl−/OH−
exchange) or cotransport of a species with opposite charge
(H+/Cl−). Monensin and valinomycin are naturally occurring
cationophores, but their underlying transport mechanisms are
fundamentally diﬀerent. Monensin has a single carboxylic acid
group that deprotonates upon metal complexation to form a
pseudomacrocyclic complex. It therefore functions as a M+/H+
antiporter (exchanger) in lipid bilayer membrane transport,
with negligible activity in facilitating M+ transport.30 This is an
electroneutral cation exchange process and will result in
perturbation of luminal pH. In contrast, valinomycin is a K+-
selective carrier; it facilitates electrogenic K+ transport without
directly aﬀecting the transmembrane pH gradient.31
Liposomes were loaded with KCl and suspended in K2SO4
external solution, with both solutions buﬀered to pH 4.5 with
citrate. Either monensin (0.1 mol %) or valinomycin (0.1 mol
%) was added alone or in combination with an anionophore
(0.2 mol %) or prodigiosin (0.005 mol %), and the rate of Cl−
eﬄux was monitored by a chloride ion-selective electrode. In
these cationophore-coupled assays, chloride eﬄux is driven by
the large Cl− concentration gradient. In the presence of an H+/
Cl− cotransporter alone, no measurable Cl− eﬄux could occur
due to the buildup of transmembrane pH gradient. For this
reason, prodigiosin must couple with monensin to combine
H+/Cl− symport and K+/H+ antiport, resulting in formal KCl
eﬄux (Figure 7c). No measurable Cl− eﬄux was observed
when prodigiosin was added with valinomycin (Figure 7c),
consistent with the nonelectrogenic nature of prodigiosin.5
Figure 7f shows that compound 7 can couple with both
monensin and valinomycin to facilitate KCl eﬄux. We have
previously shown that this is because simple neutral hydrogen
bonding anionophores such as 7 are nonspeciﬁc and can
function both as an electrogenic chloride transporter that can
couple with valinomycin and also as a H+ transporter or
functionally equivalent OH− transporter; hence, these
processes together with Cl− transport can couple with the
electroneutral K+/H+ transport by monensin.19
When thiosemicarbazones were examined in these assays, it
was found that Cl− eﬄux is only observed in the presence of
monensin but not valinomycin. This experiment demonstrates
that K+/H+ antiport facilitated by monensin couples to H+/Cl−
cotransport facilitated by the thiosemicarbazone, resulting in
overall KCl eﬄux from the liposomes. Importantly, as no
chloride eﬄux is observed in the presence of valinomycin, this
experiment demonstrates that the H+ and Cl− transport
facilitated by the thiosemicarbazone is an inseparable process
(Figure 7d and 7e). Therefore, thiosemicarbazones are
prodigiosin-like, in which chloride cannot be transported
without a proton also being transported, and the protonated
thiosemicarbazones cannot diﬀuse through the lipid bilayer
without a counteranion. Also of note, the initial rates (kinitial) of
Cl− eﬄux from these cationophore-coupled assays gave the
same trend (e.g., 1 faster than 2) for the Cl−/NO3
− exchange
assay discussed above, indicating that the electrogenic Cl− or
electroneutral H+/Cl− (or Cl−/OH−) transport facilitated by
anionophores is the rate-limiting ﬂux process with 0.1 mol % of
cationophore loading.
These results taken together are evidence that thiosemicar-
bazones must be protonated at the imino nitrogen to switch
ON transmembrane transport of chloride (Figure 8). This
results in cotransport of H+/Cl−, mimicking the nonelectro-
genic H+/Cl− symport mechanism of prodigiosin (Figure 1),
which is fundamentally diﬀerent from previously reported pH-
dependent nonspeciﬁc transporters, which are able to mediate
both electroneutral and electrogenic transport processes. This is
important, as electrogenic transporters are known to depolarize
mitochondria membrane potential13 which can complicate
biological studies of cellular processes.14 Furthermore, the EC50
of thiosemicarbazones 1 and 2 (Table 1) are signiﬁcantly lower
than the analogous phenylthioureas 4 and 5 and are also
comparable to some of the most potent synthetic anionophores
reported to date,32 hence suggesting that an overall neutral
complex (e.g., 1·H+⊃Cl−) is favorable in the transport process.
■ CONCLUSIONS
We have shown that phenylthiosemicarbazones are the ﬁrst
examples of nonelectrogenic anion transporters that show pH-
switching behavior between neutral and acidic pH conditions.
The pH-switchable transport properties are very signiﬁcant, in
particular compound 1 which has an EC50 value 640-fold times
lower at pH 4.0 than at pH 7.2 (i.e., it is a signiﬁcantly better
transporter under acidic conditions). The nonelectrogenic H+/
Cl− cotransport mechanism was shown to mimic that of
prodigiosin by using cationophore-coupled KCl eﬄux assays. In
the search for more eﬀective anionophores tailored for diﬀerent
Figure 8. Schematic overview for the acid-sensing (proton-gated)
ON/OFF chloride transport mechanism of thiosemicarbazones.
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biological studies, this work in conjunction with our most
recent work (on the study of electrogenic anionophores)19 has
shown the importance of elucidating the fundamental transport
mechanism, as most reported synthetic anionophores are
nonspeciﬁc, capable of mediating both electrogenic and
nonelectrogenic processes. The explicit pH-switchable trans-
port at pH 4.0 demonstrated by this class of transporters could
potentially be employed for targeted anion eﬄux from acidic
lysosomal vesicles in cells, gaining new insights into cellular
processes induced by anionophores.
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Peŕez-Tomaś, R. Life Sci. 2001, 68, 2025−2036.
(5) Sato, T.; Konno, H.; Tanaka, Y.; Kataoka, T.; Nagai, K.;
Wasserman, H. H.; Ohkuma, S. J. Biol. Chem. 1998, 273, 21455−
21462.
(6) Seganish, J. L.; Davis, J. T. Chem. Commun. 2005, 5781−5783.
(7) (a) Knight, N. J.; Hernando, E.; Haynes, C. J. E.; Busschaert, N.;
Clarke, H. J.; Takimoto, K.; García-Valverde, M.; Frey, J. G.; Quesada,
R.; Gale, P. A. Chem. Sci. 2016, 7, 1600−1608. (b) Soto-Cerrato, V.;
Manuel-Manresa, P.; Hernando, E.; Calabuig-Fariñas, S.; Martínez-
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Eur. J. 2011, 17, 14074−14083. (b) Sessler, J. L.; Eller, L. R.; Cho, W.-
S.; Nicolaou, S.; Aguilar, A.; Lee, J. T.; Lynch, V. M.; Magda, D. J.
Angew. Chem., Int. Ed. 2005, 44, 5989−5992. (c) Gale, P. A.; Light, M.
E.; McNally, B.; Navakhun, K.; Sliwinski, K. E.; Smith, B. D. Chem.
Commun. 2005, 3773−3775.
(10) (a) Wemmie, J. A.; Taugher, R. J.; Kreple, C. J. Nat. Rev.
Neurosci. 2013, 14, 461−471. (b) Li, T.; Yang, Y.; Canessa, C. M. Nat.
Commun. 2011, 2, 399. (c) Jasti, J.; Furukawa, H.; Gonzales, E. B.;
Gouaux, E. Nature 2007, 449, 316−323.
(11) (a) Santacroce, P. V.; Davis, J. T.; Light, M. E.; Gale, P. A.;
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